Results 71 to 80 of about 64,677 (273)

The role of 5αR and α1AR inhibitors in management of BPH

open access: yes, 2019
BPH is a common progressive condition in the aging population. Several treatment modalities have been proposed aimed at inhibiting the sympathetic input to the prostate gland with a selective α1 adrenoreceptor inhibitor and interfering with the androgen ...
Khamaysi, Majd
core  

Lower Urinary Tract Symptoms as Diagnostic Clues in Parkinsonism: A Practical Framework for Neurologists

open access: yesMovement Disorders Clinical Practice, EarlyView.
Abstract Background Lower urinary tract symptoms (LUTS) are among the most prevalent nonmotor complaints across the parkinsonian spectrum, yet they remain underutilized as diagnostic and management signals in neurology practice. Although prior reviews have characterized disease‐specific patterns of urinary dysfunction, and recent guidelines address ...
Saar Anis   +3 more
wiley   +1 more source

Could Infectious Agents Play a Role in the Onset of Age-related Macular Degeneration? A Scoping Review

open access: yesOphthalmology Science
Topic: This scoping review aims to summarize the current state of knowledge on the potential involvement of infections in age-related macular degeneration (AMD).
Petra P. Larsen, MD, PhD   +4 more
doaj   +1 more source

Effect of Finasteride on PSA and Histopathological Results in Patients Undergoing Prostate Biopsy

open access: yesMajallah-i Dānishgāh-i ’Ulūm-i Pizishkī-i Īlām, 2022
Introduction: Prostate cancer management focuses on rapid diagnosis and treatment. The present study was performed to investigate the effect of finasteride on PSA changes and biopsy results.
Saman Farshid   +4 more
doaj  

Review article on Mutraghata w.s.r. to BPH [PDF]

open access: yes, 2020
BPH is a common condition in old age. The epidemiology reveals that BPH more likely occur after the age of 40 years, with prevalence rate of 8%-60% at age 90 years.
Dr. Ranjit Singh, Dr. Upasana Priya
core   +1 more source

How Can We Personalize the Delivery of Onabotulinumtoxin‐A for Patients With Neurogenic Lower Urinary Tract Dysfunction?

open access: yesNeurourology and Urodynamics, EarlyView.
ABSTRACT Background & Aims Neurogenic lower urinary tract dysfunction (NLUTD) can produce bothersome urinary symptoms, impact quality of life, and in some cases, lead to deterioration of upper urinary tract function. Intradetrusor injection of onabotulinumtoxin‐A (BoNT‐A) is approved for NLUTD in patients who have an inadequate response to or ...
Shirley L. Wang   +2 more
wiley   +1 more source

Drug prescription before and after dialysis initiation in older patients: a nationwide study

open access: yesBMC Geriatrics
Background Older patients on dialysis have a complex regimen of drugs to manage their chronic kidney disease (CKD), associated complications, and co-morbidities.
Léa Faure   +14 more
doaj   +1 more source

Predictors of user experience and long-term use of an ambient assisted living platform by frail older adults: Results from the HomeAssist study

open access: yesComputers in Human Behavior Reports
Background and objectives: Frailty is a geriatric condition recognized as threatening independent living, while fortunately responding positively to environmental interventions.
Lucile Dupuy   +6 more
doaj   +1 more source

Urodynamic Voiding Patterns in Multiple Sclerosis

open access: yesNeurourology and Urodynamics, EarlyView.
ABSTRACT Aims This study aimed to describe urodynamic voiding patterns in patients with MS (PwMS) using standardized assessments, and to compare the performance of the available nomograms and indices for obstruction and bladder contractility. Methods PwMS and lower urinary tract symptoms underwent cystometry and pressure flow studies.
Camille Chesnel   +5 more
wiley   +1 more source

Effect of finasteride particle size reduction on its pharmacokinetic, tissue distribution and cellular permeation

open access: yesDrug Delivery, 2018
Finasteride (FSD), a specific competitive inhibitor of the steroid type-II 5α-reductase enzyme, is used in treatment of benign prostate hyperplasia (BPH) and male pattern baldness.
Tarek A. Ahmed, Ahmed M. Al-Abd
doaj   +1 more source

Home - About - Disclaimer - Privacy